A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects with Parkinson's Disease

Recruiting

Phase 1

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects with Parkinson's DiseaseA Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects with Parkinson's Disease

Sponsor:

Sumitomo Pharma America, Inc.

Code:

NCT06753331

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 40 - 69

Healthy Volunteers: Not accepted

Interventions

DSP-1083 implantation

Sham surgery treatment

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Sumitomo Pharma America, Inc. on 2025-03-25.